miR-502-mediated histone methyltransferase SET8 expression is associated with clear cell renal cell carcinoma risk.
about
miR-502-mediated histone methyltransferase SET8 expression is associated with clear cell renal cell carcinoma risk.
description
2017 nî lūn-bûn
@nan
2017年の論文
@ja
2017年学术文章
@wuu
2017年学术文章
@zh
2017年学术文章
@zh-cn
2017年学术文章
@zh-hans
2017年学术文章
@zh-my
2017年学术文章
@zh-sg
2017年學術文章
@yue
2017年學術文章
@zh-hant
name
miR-502-mediated histone methy ...... ell renal cell carcinoma risk.
@en
miR-502-mediated histone methy ...... ell renal cell carcinoma risk.
@nl
type
label
miR-502-mediated histone methy ...... ell renal cell carcinoma risk.
@en
miR-502-mediated histone methy ...... ell renal cell carcinoma risk.
@nl
prefLabel
miR-502-mediated histone methy ...... ell renal cell carcinoma risk.
@en
miR-502-mediated histone methy ...... ell renal cell carcinoma risk.
@nl
P2093
P2860
P356
P1433
P1476
miR-502-mediated histone methy ...... ell renal cell carcinoma risk.
@en
P2093
Huiran Zhang
Jinsheng Xu
Junxia Zhang
Shenglei Zhang
Yaling Bai
Yueping Liu
Zhanjun Guo
P2860
P304
P356
10.3892/OL.2017.7115
P577
2017-10-02T00:00:00Z